Vir Biotechnology

VIR

NASDAQHealth Care

Income Statement

Total Revenue$74.21M

Gross Profit$73.36M

Operating Income$-587.17M

EBITDA$-503.3M

EBIT$-523.11M

Pre-tax Income$-437.77M

Net Income$-521.96M

Cash Equivalent$263.78M

Total Debt$96.93M

Book Value$1.34B

Book Value Per Share9.85

Return on Equity (ROE)-45.37%

Return on Assets (ROA)-37.31%

Return on Invested Capital (ROI)-45.37%

Net Profit Margin-703.40%

Current Ratio8.71

Quick Ratio8.31

Long-Term Debt / Equitynull